CAJ | 학술논문

目的研究恩必普联合脑蛋白水解物注射液对血管性痴呆患者认知功能的作用。方法将90例血管性痴呆患者随机分为两组各45例，治疗组予以恩必普联合脑蛋白水解物注射液治疗，对照组用脑蛋白水解物注射液治疗。疗程1个月，治疗前后均采用简易智能状态量表(MMSE)和日常生活能力量表(ADL)评价临床疗效。结果治疗1月后，治疗组MMSE和ADL评分优于对照组，差异有统计学意义(P<0.05)。结论恩必普联合脑蛋白水解物注射液治疗血管性痴呆有效，能显著改善患者认知功能，提高生活质量。
목적연구은필보연합뇌단백수해물주사액대혈관성치태환자인지공능적작용。방법장90례혈관성치태환자수궤분위량조각45례，치료조여이은필보연합뇌단백수해물주사액치료，대조조용뇌단백수해물주사액치료。료정1개월，치료전후균채용간역지능상태량표(MMSE)화일상생활능역량표(ADL)평개림상료효。결과치료1월후，치료조MMSE화ADL평분우우대조조，차이유통계학의의(P<0.05)。결론은필보연합뇌단백수해물주사액치료혈관성치태유효，능현저개선환자인지공능，제고생활질량。
Objective To study the combination of Butylphthalide and Cerebroprotein Hydrolysate in treating vascular cognitive impairment. Methods 90 patients with vascular cognitive impairment were randomly divided into 2 groups, treatment group and control group. The treatment group of 45 cases was given Butylphthalide and Cerebroprotein Hydrolysate injection, the control group of 45 cases was only given Cerebroprotein Hydrolysate injection, with 1 month as a treatment course. The Mini-Mental State Examination(MMSE) and Activities of Daily Living(ADL) scores were used for evaluation of curative effect of the 2 groups of patients. Results After one month of treatment, The treatment group of Butylphthalide and Cerebroprotein Hydrolysate was superior to the control group of Cerebroprotein Hydrolysate injection in the the MMSE and ADL scores, there was statistical significance between 2 groups(P<0.05). Conclusion It is effective in treating vascular dementia of the combination of Butylphthalide and Cerebroprotein Hydrolysate injection, It is clear to improve patients cognitive function and the quality of life of the patients.